| Ticker | ISIN | Type | Sector | Industry | Exchange | Country | Currency | Yield (%) | Yield 1Y (%) | Yield 3Y (%) | Yield 5Y (%) | Yield 10Y (%) | Dividend CAGR 1Y (%) | Dividend CAGR 3Y (%) | Dividend CAGR 5Y (%) | Growth Streak | Freq | P/E | Payout (%) | EPS | Market Cap | Book | P/B | Beta | Next Earnings | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() CRVS Corvus Pharmaceuticals, Inc. | US2210151005 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -0.54 | 0.6B | 0.961 | 7.77 | 0.629 | N/A | ||||||
![]() DSGN Design Therapeutics, Inc. | US25056L1035 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -1.19 | 0.6B | 3.506 | 2.80 | 1.64 | N/A | ||||||
![]() CGEM Cullinan Therapeutics, Inc. | US2300311063 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -3.32 | 0.6B | 7.64 | 1.31 | -0.098 | N/A | ||||||
![]() AGMB AgomAb Therapeutics NV ADR | US00860C1027 | EQUITY | Health Care | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | 0.0 | 0.6B | -7223.242 | -0.00 | 0.27716506 | N/A | ||||||
![]() NBY NovaBay Pharmaceuticals, Inc. | EQUITY | Healthcare | Biotechnology | NYSE | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.89 | 0.0% | 5.36 | 0.6B | -0.446 | -10.65 | 0.479 | N/A | |||||||
![]() VSTM Verastem, Inc. | US92337C1045 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -4.28 | 0.6B | -0.233 | -34.59 | 0.411 | N/A | ||||||
![]() ANRO Alto Neuroscience, Inc. | US02157Q1094 | EQUITY | Healthcare | Biotechnology | NYSE | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -2.3 | 0.6B | 4.106 | 4.79 | 0.0 | N/A | ||||||
![]() ENGN enGene Holdings Inc. | CA29286M1059 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -2.29 | 0.6B | 3.224 | 2.92 | 0.0 | N/A | ||||||
![]() PRME Prime Medicine, Inc. | US74168J1016 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 0.00 | 0.0% | -1.37 | 0.6B | 0.915 | 3.90 | 2.709 | N/A | ||||||
![]() KROS Keros Therapeutics, Inc. | US4923271013 | EQUITY | Healthcare | Biotechnology | NASDAQ | United States | $ | 0.00 | 0.00 | 0.00 | 0.00 | N/A | 13.69 | 0.0% | 1.56 | 0.7B | 17.316 | 1.23 | 0.897 | N/A |